Ligand ID: C5E Drugbank ID: DB09028(Cytisine) Indication:Indicated for use in smoking cessation. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 8 | TYR A 234VAL A 221CYH C 271ILE A 223 | 1.77A | 22.29 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 4 / 8 | VAL N 108TYR N 76CYH N 90CYH N 77 | 1.69A | 20.45 | NoneNone ZN N 998 (-2.4A) ZN N 998 (-2.2A) | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 8 | TYR B 88VAL B 162CYH A 290ILE B 63 | 1.79A | 20.95 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | TYR A 217VAL A 226TYR A 207ILE A 223 | 1.73A | 15.53 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6k | BETA-2-MICROGLOBULIN (Homosapiens) | 4 / 8 | VAL B 27TYR B 10TYR B 26ILE B 7 | 1.78A | 20.29 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 5x4r | S PROTEIN (MERS-CoV) | 4 / 8 | TYR A 316TRP A 253TYR A 314ILE A 120 | 1.78A | 18.59 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 5x5f | S PROTEIN (MERS-CoV) | 4 / 8 | TYR C1192VAL C1181TYR C1186ILE C 782 | 1.61A | 9.94 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 4 / 8 | TYR B 541VAL B 563CYH B 444ILE B 565 | 1.74A | 16.35 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 8 | TYR A 139TRP A 150VAL A 172ILE A 407 | 1.36A | 16.06 | None | ||
![]() | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 4 / 8 | TYR A 689VAL A 588TYR A 483ILE A 757 | 1.40A | 12.36 | None |